Moderna (MRNA) IV into BARDA additional $472M commitment

Moderna (NASDAQ: MRNA) Moderna (NASDAQ: MRNA) July weekly call option implied volatility is at 97, August is at 102; compared to its 52-week range of 51 to 172 into Biomedical Advanced Research and Development Authority, or BARDA, making an additional commitment of up to $472M to support late stage clinical development including the expanded Phase 3 study of the company's mRNA vaccine candidate against COVID-19.

You May Also Be Interested In

• Moderna (MRNA) call put ratio 5 calls to 1 put with a focus on July 10 weekly 80 and 85 calls as share price up 6.5%
• Accelerant Holdings (ARX) 8500 contracts of July 15 calls active as share price up 8.7%
• CNH Industrial (CNH) 3800 contracts of August 12.50 calls trade, share price down 2%